Zobrazeno 1 - 10
of 17
pro vyhledávání: '"AMI MURAKAMI"'
Publikováno v:
F1000Research, Vol 12 (2023)
Immunoglobulin G4 (IgG4)-related disease is a systemic inflammatory disorder characterized by tubulointerstitial nephritis with IgG4-positive plasma cell infiltration. We report the case of an 84-year-old male who presented with a history of dyspnea
Externí odkaz:
https://doaj.org/article/c6f76165e2a147a9b39f2cdec4185593
Autor:
Akira Mima, Rina Lee, Ami Murakami, Hidemasa Gotoda, Ryosuke Akai, Sayumi Kidooka, Takahiro Nakamoto, Suguru Kido, Shinji Lee
Publikováno v:
Metabolism Open, Vol 19, Iss , Pp 100251- (2023)
Background: In the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease trial, finerenone reduced the risk of cardiovascular events in patients with chronic kidney disease (CKD) and type 2 diabetes, while in the Fi
Externí odkaz:
https://doaj.org/article/13b25c1a51cb4665832d3bfd1de85229
Publikováno v:
F1000Research, Vol 12 (2023)
Immunoglobulin G4 (IgG4)-related disease is a systemic inflammatory disorder characterized by tubulointerstitial nephritis with IgG4-positive plasma cell infiltration. We report the case of an 84-year-old male who presented with a history of dyspnea
Externí odkaz:
https://doaj.org/article/0f5cda1a5554411a830b8b7e6883a78d
Autor:
Jun Shimizu, Tadahiro Sasaki, Ritsuko Koketsu, Ryo Morita, Yuka Yoshimura, Ami Murakami, Yua Saito, Toshie Kusunoki, Yoshihiro Samune, Emi E. Nakayama, Kazuo Miyazaki, Tatsuo Shioda
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Many therapeutic antibodies (Abs) and mRNA vaccines, both targeting SARS-CoV-2 spike protein (S-protein), have been developed and approved in order to combat the ongoing COVID-19 pandemic. In consideration of these developments, a common con
Externí odkaz:
https://doaj.org/article/8a37b41caa644a66a3c211598c57d82d
Publikováno v:
Metabolism Open, Vol 18, Iss , Pp 100240- (2023)
Background: In rodents, glomerular expression of insulin receptor substrate 1 (IRS1) is decreased in diabetic kidney disease (DKD) and reduced associated functioning is involved in the development and progression of DKD. This study aimed to evaluate
Externí odkaz:
https://doaj.org/article/c08e640378b24c1c9d75566a74365e49
Publikováno v:
Metabolism Open, Vol 17, Iss , Pp 100236- (2023)
Background: This meta-analysis was conducted to investigate the effects of incretin-based therapeutic agents, including the latest agent tirzepatide, on renal outcomes in patients with type 2 diabetes. Methods: MEDLINE (via PubMed) and Cochrane datab
Externí odkaz:
https://doaj.org/article/8790ea2497e64a229b660aab8d89d47c
Autor:
Jun Shimizu, Tadahiro Sasaki, Atsushi Yamanaka, Yoko Ichihara, Ritsuko Koketsu, Yoshihiro Samune, Pedro Cruz, Kei Sato, Naomi Tanga, Yuka Yoshimura, Ami Murakami, Misuzu Yamada, Kiyoe Itoi, Emi E. Nakayama, Kazuo Miyazaki, Tatsuo Shioda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many vaccine trials have been initiated. An important goal of vaccination is the development of neutralizing antibody (Ab) against SARS-CoV-2. However, the
Externí odkaz:
https://doaj.org/article/914243e72473467dab29fe6d8b6f93df
Autor:
Jun Shimizu, Tadahiro Sasaki, Ritsuko Koketsu, Ryo Morita, Yuka Yoshimura, Ami Murakami, Yua Saito, Toshie Kusunoki, Yoshihiro Samune, Emi E. Nakayama, Kazuo Miyazaki, Tatsuo Shioda
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/e7a68de209cf4da4a6b4dc491395788c
Autor:
AKIRA MIMA, HIDEMASA GOTODA, SHINJI LEE, RINA LEE, AMI MURAKAMI, RYOSUKE AKAI, SAYUMI KIDOOKA, KEISHI MATSUMOTO, YUTA SAITO, SHINJI HISHIDA, TAKAHIRO NAKAMOTO, SUGURU KIDO, TAKAYOSHI HAMADA
Publikováno v:
In Vivo; May/Jun2024, Vol. 38 Issue 3, p1266-1270, 5p
Autor:
AKIRA MIMA, SAYUMI KIDOOKA, TAKAHIRO NAKAMOTO, SUGURU KIDO, HIDEMASA GOTODA, RINA LEE, AMI MURAKAMI, SHINJI LEE
Publikováno v:
In Vivo; Jan/Feb2024, Vol. 38 Issue 1, p308-312, 5p